Navigation Links
New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF
Date:6/30/2009

AMSTERDAM, The Netherlands, June 30 /PRNewswire/ --

- "Study Could Have Major Impact on the Decision-Making Process With Respect to Infertility Treatment"

New data from an economic analysis presented today at this year's European Society of Human Reproduction and Embryology (ESHRE) congress showed that, within the parameters of the simulation model used, the in vitro fertilisation (IVF) treatment MENOPUR (highly-purified human menopausal gonatropin or HP-hMG) offered considerable cost-savings over recombinant follicle stimulating hormone (rFSH).[1] The cost-effectiveness of HP-hMG compared with rFSH suggested by this data could make it a more attractive choice for use in infertility treatment within a fixed healthcare budget.

In today's difficult global financial situation, the cost-effectiveness of infertility treatments, such as IVF, is more important than ever. Experiencing fertility problems is deeply distressing and isolating for couples and the cost of treatment is one of many considerations for people seeking treatment. A recent audit of European infertility patient groups showed that infertile couples are calling for clear information on the cost-effectiveness, as well as the efficacy of individual treatments.[2]

HP-hMG and rFSH are two commonly used hormonal therapies belonging to the class of drugs known as gonadotropins that enhance egg production in IVF treatment. HP-hMG, contains both FSH and hCG-driven (human chorionic gonadotropin) LH-activity (luteinizing hormone). In contrast, rFSH is a recombinant product and contains only rFSH.

"Until recently, discussions regarding funding for infertility treatment services have been hindered by a relative paucity of economic studies of the specific treatments," points out study investigator Dr Jaro Wex from PharmArchitecture, UK.

"Our new study compared success rates and value for money of gonadot
'/>"/>

SOURCE Ferring Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
2. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
4. Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis
5. New Data from the Framingham Heart Study Supports PAT Technology to Diagnose Early Cardiovascular Disease
6. Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
7. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
8. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
9. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
10. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
11. New Clinical Data Further Supports Chromium Picolinates Role in Enhancing Brain Activity in Older Adults

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)..., EATONTOWN, N.J., Nov. 5 /PRNewswire-FirstCall/...the emerging field of biologic products for regene...or the third quarter ended September 30, 2009. ,...s on the release of our three new biologic product...Technology and Plexur M® Innovative Grafting,...
(Date:11/5/2009)..., POINT RICHMOND, Calif., Nov. 5 /PRNewswire-Fir...: TSPT ), a specialty pharmaceutical company focu...oprietary products that address important therapeu...unced it will host a webcast and teleconference wi...ial results on Thursday, November 12, 2009, at 5:0...
(Date:11/5/2009)..., EDINA, Minn., Nov. 5 ARKRAY, I...tes self-monitoring systems, today announced that ...and Drug Administration for its new GLUCOCARD Vita...eter and strip platform, which ARKRAY will make av...ected to be a significant complement to the existi...
Breaking Medicine Technology:Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2ARKRAY, Inc. Receives FDA Clearance for New GLUCOCARD(R) Vital(TM) Blood Glucose Monitoring System 2Living in U S May Raise Hispanics Cancer Risk 53835 1Living in U S May Raise Hispanics Cancer Risk 53835 2Living in U S May Raise Hispanics Cancer Risk 53835 3China Sky One Medical Inc Appoints New Independent Director 13412 1China Sky One Medical Inc Appoints New Independent Director 13412 2China Sky One Medical Inc Appoints New Independent Director 13412 3Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 1Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 2Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 3Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 4Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 5
... Oct. 30 In,conjunction with QIAGEN,s Third Quart...n to its conference call which will be broadcast l... at 9:30 a.m. EST, with Peer M.,Schatz, President ...ief,Financial Officer. What: QIAGEN N.V. -- T... Tuesday, November 6, 2007 at 9:30 a.m. EST, Whe...
...ct. 30 Emphasys Medical, Inc.,today announced tha...e,Zephyr(R) Endobronchial Valve (EBV) has been acc...Drug Administration (FDA) and has been granted,exp...ive treatment option,intended to help patients wit...xpedited review based on the potential of endobron...
Other Medicine Technology:QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Third Quarter 2007 Earnings Conference Call on the Web 2Emphasys Medical Granted Expedited Review From FDA for Zephyr(R) Endobronchial Valve 2Emphasys Medical Granted Expedited Review From FDA for Zephyr(R) Endobronchial Valve 3
(Date:11/7/2009)...TON, Nov. 7, The Americ...9 Benjamin Rush Award for Citizenship and Communit...ist from Chicago, IL. The award recognizes physici...nal call of duty to make an outstanding public ser...aff received the award today during the opening se...
(Date:11/7/2009)...TON, Nov. 7 Calling this a "defini...MA), the AMA President J. James Rohack, M.D., toda... from all state and medical specialty societies at...g meeting, where health system reform will top the...-bin/prnh/20081209/AMALOGO ) ,, "Over the nex...
(Date:11/7/2009)...own: "Faithful Catholics have a responsibility to ...tiate the status quo." ,, WASHINGTON, Nov. 7 ... president Judie Brown released the following stat... support Speaker Nancy Pelosi,s Affordable Health ...dment preserving the status quo for abortion is vo...
(Date:11/7/2009)..., Nov. 7 Americans United for Life Action endorse...k-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith...oney from going to abortion in health care reform....nd CEO Dr. Charmaine Yoest said, "Americans United...worth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amend...
(Date:11/7/2009)...ht back to stem a growing problem across the U.S. ...early half of students at four-year colleges do it...ge drinking -- downing five or more alcoholic drin...fying alcohol as a drug," said Jenny Hwang, associ...g center at Stony Brook University on Long Island,...
Breaking Medicine News(10 mins):Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 3
...hrax vaccine may offer a faster and easier way to ... in the event of // a deadly bioterror attack. Sci...ine that could potentially be inhaled through the ... protein. Researchers say the powdered formula is ...
...deliver much larger radiation doses to the organs ...ered during a full-body CT scan // is nearly 100 t...s the risk of cancer death from a single full-body...tive annual scans carry much higher risks. Based o...
...dy shows smokers under age 40 are five-times more ...ir age. Researchers examined // all non-fatal hear...ages of 33 and 64 from 21 countries, 18,762 of whi... 39.In the study, smoking also accounted for 65 pe...
... in every 600 babies in the United States is born ... the baby is born with cleft only // and no other ...new gene test that will help predict if a couple w... early fetal development. Researchers identifi...
...le consider long, continuous workouts to be benefi...ervals may be a more effective way // to lower fat...termittent exercises affect triglyceride levels. T... meal and did not exercise at all. On the second d...
...’s disease affects millions of people worldwide . ... people. //The causes of Alzheimer’s disease are s... shows a centuries-old herbal remedy might be the ...les, and some were given placebos. In a word recal...
Other Medicine News:
...ased, 2-8-channel system for measuring bioelectric...optic nerve. The basic set comprises: computer dev...ioelectrical amplifier, electrodes and checkerboar...o install. The recorded curves are displayed on a ...
Veris Fundus
Sinoscopy Trocar And Cannula
Coakley Antrum Trocar
Medicine Products: